← Back to Clinical Trials
Recruiting NCT07208942

NCT07208942 Diagnosis Value of Interoceptive EEG Indicators by Rectal Stimulation in DoC

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07208942
Status Recruiting
Phase
Sponsor YiLin Zhao
Condition Disorders of Consciousness
Study Type OBSERVATIONAL
Enrollment 45 participants
Start Date 2024-12-01
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Rectal Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 45 participants in total. It began in 2024-12-01 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Study on the Significance and Value of Interoception-Related Indicators in the Classification of Patients with Disorders of Consciousness (DoC) via Rectal Stimulation

Eligibility Criteria

Inclusion Criteria: * Patients with non-acute Disorders of Consciousness (DoC) (disease course ≥ 28 days). * Aged 18 years or older. * No symptoms of fever, infection, or other similar conditions within 15 days. * No use of sedatives within 15 days. * No use of any drugs that may alter gastrointestinal motility within 7 days prior to testing. * Family members of participating patients have provided consent and signed the informed consent form. Exclusion Criteria: * Patients with functional impairments caused by developmental psychiatric disorders or neurological diseases. * Patients with untreated epilepsy. * Untreated cerebral edema. * Patients with unstable vital signs. * A history of intestinal diseases. * A history of abdominal surgery other than simple appendectomy or simple cholecystectomy. * Organic diseases such as spinal cord injury, traumatic brain injury, and thyroid dysfunction.

Contact & Investigator

Central Contact

YiLin Zhao

✉ 2567158152@qq.com

📞 18850147114

Frequently Asked Questions

Who can join the NCT07208942 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Disorders of Consciousness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07208942 currently recruiting?

Yes, NCT07208942 is actively recruiting participants. Contact the research team at 2567158152@qq.com for enrollment information.

Where is the NCT07208942 trial being conducted?

This trial is being conducted at Hefei, China, Hangzhou, China.

Who is sponsoring the NCT07208942 clinical trial?

NCT07208942 is sponsored by YiLin Zhao. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology